drugset / Trial / NCT00149877
Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation
RandomizedParallel-groupDouble-blindTreatment
Summary
Tegaserod (HTF919) is an aminoguanidine indole compound and a member of a new class of subgroup-selective 5-hydroxytryptamine (5-HT) agonists. The aim of this study is to investigate the efficacy, safety and tolerability of tegaserod on bowel habits in patients with CC.
Timeline
- Start
- 2004-04
- Primary completion
- —
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tegaserod | Small molecule | — | — |